Robert J. De Knegt

Robert J. De Knegt

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 212 publications

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study.

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study.

Journal: The lancet. Gastroenterology & hepatology

Published: January 05, 2026

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.

Journal: Lancet (London, England)

Published: September 17, 2025

Underuse of statins in MASLD despite population-based associations with lower liver stiffness.

Underuse of statins in MASLD despite population-based associations with lower liver stiffness.

Journal: JHEP reports : innovation in hepatology

Published: September 08, 2025

Persistent loss of intrahepatic IFN-γ in HBV is linked to selective impairment of liver-resident CXCR6+NK cells despite long-term NUC therapy.

Persistent loss of intrahepatic IFN-γ in HBV is linked to selective impairment of liver-resident CXCR6+NK cells despite long-term NUC therapy.

Journal: JHEP reports : innovation in hepatology

Published: September 08, 2025

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt.

Journal: Alimentary pharmacology & therapeutics

Published: May 23, 2025

Association Between Sustained Virological Response and Adverse Liver-Related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis.

Association Between Sustained Virological Response and Adverse Liver-Related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 01, 2025

Integrating Gut Microbiome and Metabolome to Gain Insight into Metabolic Dysfunction-Associated Steatotic Liver Disease.

Integrating Gut Microbiome and Metabolome to Gain Insight into Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Gastro hep advances

Published: February 27, 2025

Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction.

Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction.

Journal: Hepatology (Baltimore, Md.)

Published: December 17, 2024

Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue?

Editorial: Navigating the Beta-Blocker Dilemma in Advanced Liver Cirrhosis-When Is the Right Time to Discontinue?

Journal: Alimentary pharmacology & therapeutics

Published: September 23, 2024

The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysis.

The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysis.

Journal: Hepatology communications

Published: September 19, 2024

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus.

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus.

Journal: Metabolism: clinical and experimental

Published: June 25, 2024

The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B.

The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 02, 2024

Showing 1-12 of 212

Last Updated: 09/26/2026